跳至主要内容
临床试验/CTRI/2022/02/040197
CTRI/2022/02/040197已完成未知

Early antiseizure medication tapering in children and adolescents aged 2-18 years with single calcified parenchymal neurocysticercosis in a low-risk subgroup identified by risk assessment: a single arm intervention study

All India Institute of Medical Science New Delhi0 个研究点目标入组 34 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
34

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • a)Children and adolescents aged 2-18 years with single parenchymal calcified or granular NCC with follow up from viable NCC stage
  • b)Seizure free on ASM for 6-9 months or12-15 months
  • C) resolving or calcified NCC @ 6 month CECT

排除标准

  • h/o status epilepticus requiring hospitalization
  • three or more episodes of seizures after starting ASM
  • significant perilesional edema ( 2 times the size of calcified focus or any size of perilesional edema with calcified focus >1 cm.
  • any other brain pathogy ( hippocampal sclerosis, vascular malmormation, old insult sequale)

研究者

发起方
All India Institute of Medical Science New Delhi

相似试验